BioCentury
ARTICLE | Financial News

Kenta raises $10.3 million

March 13, 2009 12:38 AM UTC

Kenta (Berne, Switzerland) raised CHF12 million ($10.3 million) in a series B round. Existing investors Ingro Finanz; Varuma; and Regos participated. Kenta's lead compound is KBPA101, a human IgM mAb ...